Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis.
Hematology (Amsterdam, Netherlands)(2023)
摘要
There was no difference between pegfilgrastim and filgrastim for the rate of FN. The use of pegfilgrastim was still associated with rates of FN, grade 4 FN, severe neutropenia, and treatment delays due to FN in pediatric cancer patients.
更多查看译文
关键词
Granulocyte colony-stimulating factor,adolescents,cancer treatment,children,febrile neutropenia,meta-analysis,neutropenia,treatment delay
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要